HEILONGJIANG ZBD PHARMACEUTICAL financial statements, including revenue, expenses, profit, and loss

The total revenue of 603567 for the last quarter is 835.28 M CNY, and it's 20.06% lower compared to the previous quarter. The net income of Q3 23 is 131.92 M CNY.